Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Scienture Holdings (SCNX) Divestments (2023 - 2024)

Scienture Holdings' Divestments history spans 2 years, with the latest figure at -$774.0 for Q2 2024.

On a quarterly basis, Divestments changed N/A to -$774.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $29.6 million, a N/A change, with the full-year FY2024 number at $29.9 million, up 43445.42% from a year prior.
Divestments hit -$774.0 in Q2 2024 for Scienture Holdings, down from $29.9 million in the prior quarter.
Over the last five years, Divestments for SCNX hit a ceiling of $29.9 million in Q1 2024 and a floor of -$351532.0 in Q3 2023.